
FDA Approves First Drug for Rare Bone Disease After 30 Years
A new medicine called Pasatru just won FDA approval for fibrodysplasia ossificans progressiva, a devastating disease that turns muscle into bone. The breakthrough could help patients maintain mobility and live longer after three decades of research.

















